BRCA2 and ovarian carcinoma: Germline mutations in these genes represent significant risk factors for developing HGSOC: for a woman with a BRCA1 mutation, the risk of developing epithelial ovarian cancer is 39–46%, and with a BRCA2 mutation, 12–20% (26).